Correction to: Journal of Public Health: From Theory to Practice.

https://doi.org/10.1007/s10389-019-01161-6

line 67.

Studies indicate an undersupply (Dressler et al. 2015; Jost et al. 2015; Kerkemeyer et al. 2017; Potempa et al. 2019; Wissel et al. 2016).

line 145.

In summary a proportion of 20% patients with spasticity after stroke - those who suffer from ULS and are suitable for therapy with botulinum toxin - were included in the model. Mortality after stroke was assumed to be 32% for women and 24% for men (Bronnum-Hansen et al. 2001).

The original version has been corrected.